BJ3-27146-09328
4 vaccinations
10 coded responses
46 check-ins
10 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 483 / MI
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
VWX-75230-99504
Child or adolescent in my care · Male · 2021-11-12
Timeline
-
2020-12-28
Registered in v-safe
-
2020-12-28
Dose 1 — Moderna
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Itching · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-01-04
Survey response — day 7, dose 1MedDRA: Rash — Feeling: Good · Rash, not including the immediate area around the injection siteFree text: Rash is mild on left forearm and may be from recent oral lamisilMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
- 2021-01-18
-
2021-01-25
Dose 2 — Moderna
-
2021-02-01
Survey response — day 7, dose 2MedDRA: Adverse reaction — Feeling: Fair · Site: Pain, Redness · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: These symptoms occurred on January 26-27th and resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-16
- 2021-02-22
- 2021-03-01
- 2021-03-10
- 2021-04-26
- 2021-07-26
-
2021-10-22
Dose 3 — Moderna
- 2021-10-24
-
2021-10-25
Survey response — days 1–6 daily, dose 3MedDRA: Cough — Feeling: FairFree text: intermittent coughingMedDRA releases: 2024-11 · check-in free text available
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-27
- 2021-10-28
-
2021-10-29
Survey response — day 7, dose 3MedDRA: Headache — Feeling: Good · HeadacheFree text: Mild HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-11-12
- 2021-11-20
-
2021-11-26
Survey response — day 35, dose 3MedDRA: Headache — Feeling: FairFree text: Intermittent headachesMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Survey response — day 42, dose 3MedDRA: Vaginal haemorrhage — Feeling: GoodFree text: irregular vaginal spotting (mild)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Survey response — 3 months, dose 3MedDRA: Menstruation irregular, Vaginal haemorrhage — Feeling: FairFree text: Intermittent vaginal spotting and irregular periods, unsure if vaccine related?MedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
-
2022-09-16
Dose 4 — Moderna
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
-
2022-09-21
Survey response — days 1–6 daily, dose 4MedDRA: Back pain, Pre-existing disease — Feeling: FairFree text: back pain flaring but could be from weather changesMedDRA releases: 2024-11 · check-in free text available
- 2022-09-22
- 2022-09-23
-
2022-09-30
Survey response — day 14, dose 4MedDRA: SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Upper respiratory infection that started on 9/24 and COVID19 PCR test negative on 9/27/22.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — day 14, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-03
-
2022-10-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-07
- 2022-10-14
-
2022-10-21
Survey response — day 35, dose 4MedDRA: Exposure to SARS-CoV-2, Fatigue, Respiratory symptom, SARS-CoV-2 test positive — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Tested positive for COVID19 on 10/19/22 with rapid home test. Husband came down with COVID19 first. Started Paxlovid the same day due to fatigue and symptoms of mild chest congestion. No fevers.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Report sent to call center — day 35, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-10-24
- 2022-10-25
-
2022-10-25
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-28
- 2022-12-18
- 2023-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Moderna | |
| 2 | 2021-01-25 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-09-16 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 1 — day 7, dose 1
Systemic reaction (other): Rash is mild on left forearm and may be from recent oral lamisil
Release 3 — day 7, dose 2
Systemic reaction (other): These symptoms occurred on January 26-27th and resolved.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): intermittent coughing
Release 10 — day 7, dose 3
Systemic reaction (other): Mild Headache
Release 10 — day 35, dose 3
Symptoms: Intermittent headaches
Release 10 — day 42, dose 3
Symptoms: irregular vaginal spotting (mild)
Release 11 — 3 months, dose 3
Symptoms: Intermittent vaginal spotting and irregular periods, unsure if vaccine related?
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): back pain flaring but could be from weather changes
Release 12 — day 14, dose 4
Symptoms: Upper respiratory infection that started on 9/24 and COVID19 PCR test negative on 9/27/22.
Release 12 — day 35, dose 4
Symptoms: Tested positive for COVID19 on 10/19/22 with rapid home test. Husband came down with COVID19 first. Started Paxlovid the same day due to fatigue and symptoms of mild chest congestion. No fevers.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Vaginal haemorrhage | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Back pain | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Pre-existing disease | · | · | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release